SVCM
CGON icon

Saturn V Capital Management’s CG Oncology CGON Stock Holding History

Saturn V Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-579,895
Closed -$23.4M – 21
2025
Q3 		$23.4M Sell
579,895
-6,752
-1% -$196K 5.12% 8
2025
Q2 		$15.3M Buy
586,647
+8,951
+2% +$216K 6.18% 7
2025
Q1 		$14.1M Sell
577,696
-15,566
-3% -$438K 7.14% 3
2024
Q4 		$17M Buy
593,262
+73,143
+14% +$2.5M 6.66% 4
2024
Q3 		$19.6M Buy
+520,119
New +$18.2M 7.01% 4

Other funds holding CGON

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Saturn V Capital Management's CGON Position: Q4 2025 in Review

Saturn V Capital Management sold out of CG Oncology (CGON) in Q4 2025, closing a stake of 579,895 shares — an estimated $23.4M sold.

Saturn V Capital Management first reported a position in CGON in Q3 2024 and held it in 5 quarters. The position peaked at $23.4M in Q3 2025. 195 funds tracked by Wall St. Rank hold CGON as of Q4 2025.

  • Saturn V Capital Management reported no remaining CG Oncology position as of Q4 2025 after selling out during the quarter.
  • Saturn V Capital Management sold 579,895 CG Oncology shares in Q4 2025, an estimated $23.4M.
  • Saturn V Capital Management first reported a position in CG Oncology in Q3 2024 and held it in 5 quarters.
  • Saturn V Capital Management's CG Oncology position peaked at $23.4M in Q3 2025.
  • 195 funds tracked by Wall St. Rank held CG Oncology as of Q4 2025.

Based on Saturn V Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.